↓ Skip to main content

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

Overview of attention for article published in The Lancet Diabetes & Endocrinology, September 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
8 news outlets
twitter
38 X users
facebook
1 Facebook page

Citations

dimensions_citation
167 Dimensions

Readers on

mendeley
127 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
Published in
The Lancet Diabetes & Endocrinology, September 2013
DOI 10.1016/s2213-8587(13)70111-6
Pubmed ID
Authors

Mark R Rigby, Linda A DiMeglio, Marc S Rendell, Eric I Felner, Jean M Dostou, Stephen E Gitelman, Chetanbabu M Patel, Kurt J Griffin, Eva Tsalikian, Peter A Gottlieb, Carla J Greenbaum, Nicole A Sherry, Wayne V Moore, Roshanak Monzavi, Steven M Willi, Philip Raskin, Antoinette Moran, William E Russell, Ashley Pinckney, Lynette Keyes-Elstein, Michael Howell, Sudeepta Aggarwal, Noha Lim, Deborah Phippard, Gerald T Nepom, James McNamara, Mario R Ehlers, the T1DAL Study Team

X Demographics

X Demographics

The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Denmark 1 <1%
Italy 1 <1%
Unknown 123 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 15%
Student > Master 18 14%
Student > Bachelor 16 13%
Student > Ph. D. Student 11 9%
Other 8 6%
Other 26 20%
Unknown 29 23%
Readers by discipline Count As %
Medicine and Dentistry 50 39%
Agricultural and Biological Sciences 9 7%
Nursing and Health Professions 9 7%
Biochemistry, Genetics and Molecular Biology 8 6%
Immunology and Microbiology 7 6%
Other 15 12%
Unknown 29 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 86. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2013.
All research outputs
#501,788
of 25,837,817 outputs
Outputs from The Lancet Diabetes & Endocrinology
#414
of 2,163 outputs
Outputs of similar age
#3,884
of 216,103 outputs
Outputs of similar age from The Lancet Diabetes & Endocrinology
#4
of 42 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,163 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 76.4. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 216,103 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.